A Double-Blind Trial of Clonazepam in Benign Essential Tremor

Abstract
Clonazepam has been reported to be of some value in the treatment of benign essential tremor in open trials. The efficacy of clonazepam was evaluated in a double-blind placebo-controlled study using up to 4 mg/day. By a variety of objective measures, clonazepam was not found to be an effective form of therapy.

This publication has 0 references indexed in Scilit: